Reaction
Osteomalacia reporting signals
As of the last recalculation, Osteomalacia appears in 1,539 FAERS reports alongside 30 co-occurring drug terms. The strongest observed disproportionality signal is TENOFOVIR DISOPROXIL FUMARATE (PRR 121.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tenofovir Disoproxil Fumarate | 249 | 121.4 | 122.3 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate | 64 | 100.3 | 101.0 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide | 64 | 89.7 | 90.3 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 249 | 87.9 | 88.4 |
| Entecavir | 64 | 77.3 | 77.7 |
| Lamivudine Oral | 131 | 76.5 | 76.8 |
| Lamivudine | 153 | 74.3 | 74.6 |
| Tenofovir Disoproxil Fumarate Tablets | 43 | 69.3 | 69.6 |
| Emtricitabine And Tenofovir Alafenamide | 54 | 66.7 | 67.0 |
| Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate | 74 | 58.0 | 58.2 |
| Lopinavir And Ritonavir | 38 | 38.9 | 39.0 |
| Efavirenz | 20 | 24.6 | 24.6 |
| Abacavir Sulfate | 17 | 23.9 | 23.9 |
| Atazanavir | 24 | 22.9 | 23.0 |
| Dolutegravir Sodium | 14 | 21.2 | 21.2 |
| Zidovudine | 17 | 17.4 | 17.4 |
| Ritonavir | 34 | 16.1 | 16.1 |
| Raltegravir | 19 | 15.7 | 15.8 |
| Calcitriol Capsules 0.25 Mcg | 19 | 13.0 | 13.0 |
| Calcitriol Capsules 0.5 Mcg | 19 | 13.0 | 13.0 |
| Iron Sucrose | 9 | 12.8 | 12.8 |
| Calcitriol | 19 | 12.8 | 12.8 |
| Darunavir | 13 | 11.7 | 11.7 |
| Zoledronic Acid | 32 | 11.0 | 11.0 |
| Paricalcitol | 11 | 10.6 | 10.6 |
| Asfotase Alfa | 7 | 9.5 | 9.5 |
| Ritonavir 100 Mg | 10 | 9.1 | 9.1 |
| Nevirapine | 6 | 9.0 | 9.0 |
| Zonisamide | 9 | 8.3 | 8.3 |
| Ifosfamide | 11 | 7.0 | 7.0 |